Handbook of Clinical Psychopharmacology for TherapistsThe Handbook of Clinical Psychopharmacology for Therapists has long been the definitive reference book for mental health clinicians and anyone else looking for clear, reliable information about the medical treatment of mental health issues. Thousands of therapists keep this invaluable book on their shelves to quickly reference drug facts for their clients. Now in its sixth edition, this fully revised handbook has been updated with the results of the latest medical research. This new edition also includes quick-reference guides for each mental health disorder that indicate when you should consider referring a client for medical treatment. This handbook makes it simple to:
|
From inside the book
Results 1-5 of 43
Page 32
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 33
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 35
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 36
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Page 37
Sorry, this page's content is restricted.
Sorry, this page's content is restricted.
Common terms and phrases
abnormalities abuse activity acute ADHD adolescents alcohol antianxiety anticonvulsants antidepressants antipsychotic medications antipsychotics anxiety disorders anxiety symptoms associated atypical Axis behavior benzodiazepines Beta blockers biological bipolar disorder blockers blood pressure borderline brain bupropion Buspirone carbamazepine cause chapter chronic clinical clinician cognitive decreased diagnosis divalproex doctor dopamine dosage dose drug interactions DSM-IV-TR dysfunction emotional enzymes episode especially etiology Figure fluoxetine functioning impaired increased inhibitors insomnia Interacting Drug levels lithium major depression mania manic MAOIs medication treatment mental metabolism molecules mood stabilizers nerve cells nervous system neurons neurotransmitters norepinephrine obsessive-compulsive obsessive-compulsive disorder occur olanzapine onset panic disorder patients percent personality disorder pharmacist pharmacologic potentially prescribed psychiatric disorders psychological Psychopharmacology psychosis psychotherapy psychotropic medications PTSD receptors reduce response result reuptake risk schizophrenia second-generation antipsychotics sedation serotonin severe side effects significant sleep SSRIs stimulants stress stressors studies substance suicide syndrome therapeutic therapist therapy tion toxicity treat venlafaxine